[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease]

Autor:	Jan, Håkansson, Anders, Hernborg
Rok vydání:	2010
Předmět:	Primary Prevention Sex Factors Aspirin Fibrinolytic Agents Cardiovascular Diseases Risk Factors Age Factors Secondary Prevention Humans
Zdroj:	Lakartidningen. 107(5)
ISSN:	0023-7205
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ab75bca7141a11a2d357c73158362611 https://pubmed.ncbi.nlm.nih.gov/20297567 Zobrazit plný text záznamu